Literature DB >> 33494789

Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease.

Alessandra Marchesi1, Donato Rigante2,3, Rolando Cimaz4,5, Angelo Ravelli6, Isabella Tarissi de Jacobis1, Alessandro Rimini7, Fabio Cardinale8, Marco Cattalini9, Andrea De Zorzi1, Rosa Maria Dellepiane10, Patrizia Salice11, Aurelio Secinaro1, Andrea Taddio12,13, Paolo Palma1, Maya El Hachem1, Elisabetta Cortis14, Maria Cristina Maggio15, Giovanni Corsello15, Alberto Villani1.   

Abstract

Aim of these revised recommendations for the general management of Kawasaki disease is to encourage its prompter recognition and warrant the most appropriate therapy, based on ascertained scientific data, raising awareness of the complications related to misdiagnosis or delayed treatment. A set of 20 synthetic operative statements is herein provided, including the definition of Kawasaki disease, its protean presentations, clinical course and seminal treatment modalities of all disease phases. The application of these recommendations should improve prognosis of Kawasaki disease and prevent the progression to permanent vascular abnormalities, thereby diminishing morbidity and mortality.

Entities:  

Keywords:  Aspirin; Children; Coronary artery abnormalities; Intravenous immunoglobulin; Kawasaki disease

Year:  2021        PMID: 33494789      PMCID: PMC7830049          DOI: 10.1186/s13052-021-00962-4

Source DB:  PubMed          Journal:  Ital J Pediatr        ISSN: 1720-8424            Impact factor:   2.638


  85 in total

1.  Application of percutaneous transluminal coronary angioplasty to coronary arterial stenosis in Kawasaki disease.

Authors:  T Ino; K Akimoto; M Ohkubo; K Nishimoto; K Yabuta; J Takaya; H Yamaguchi
Journal:  Circulation       Date:  1996-05-01       Impact factor: 29.690

2.  Aspirin and Reye syndrome.

Authors:  Dominic A Fitzgerald
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

Review 3.  Kawasaki disease: insights into pathogenesis and approaches to treatment.

Authors:  Stanford T Shulman; Anne H Rowley
Journal:  Nat Rev Rheumatol       Date:  2015-04-28       Impact factor: 20.543

Review 4.  Kawasaki disease.

Authors:  Fernanda Falcini
Journal:  Curr Opin Rheumatol       Date:  2006-01       Impact factor: 5.006

Review 5.  Overview of the rarest causes of fever in newborns: handy hints for the neonatologist.

Authors:  Domenico Umberto De Rose; Maria Coppola; Francesca Gallini; Luca Maggio; Giovanni Vento; Donato Rigante
Journal:  J Perinatol       Date:  2020-07-27       Impact factor: 2.521

6.  Prophylactic use of clopidogrel in paediatric cardiac patients.

Authors:  C A Hanke; B Stiller; L Nakamura; J Grohmann; B Zieger
Journal:  Klin Padiatr       Date:  2012-03-22       Impact factor: 1.349

7.  Clinical features of recurrent Kawasaki disease and its risk factors.

Authors:  Hai-ming Yang; Zhong-Dong Du; Pei-pei Fu
Journal:  Eur J Pediatr       Date:  2013-07-26       Impact factor: 3.183

Review 8.  The role of echocardiography in Kawasaki disease.

Authors:  Brian W McCrindle; Barbara Cifra
Journal:  Int J Rheum Dis       Date:  2017-11-19       Impact factor: 2.454

9.  Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas.

Authors:  Fernanda Falcini; Serena Capannini; Donato Rigante
Journal:  Pediatr Rheumatol Online J       Date:  2011-07-20       Impact factor: 3.054

10.  Efficacy between low and high dose aspirin for the initial treatment of Kawasaki disease: Current evidence based on a meta-analysis.

Authors:  Xiaolan Zheng; Peng Yue; Lei Liu; Changqing Tang; Fan Ma; Yi Zhang; Chuan Wang; Hongyu Duan; Kaiyu Zhou; Yimin Hua; Gang Wu; Yifei Li
Journal:  PLoS One       Date:  2019-05-22       Impact factor: 3.240

View more
  10 in total

Review 1.  Association of Genetic Polymorphisms in Kawasaki Disease with the Response to Intravenous Immunoglobulin Therapy.

Authors:  E Sapountzi; L Fidani; A Giannopoulos; A Galli-Tsinopoulou
Journal:  Pediatr Cardiol       Date:  2022-07-30       Impact factor: 1.838

2.  [Pediatric expert consensus on the application of aspirin in Kawasaki disease].

Authors: 
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-06-15

3.  Pediatric expert consensus on the application of glucocorticoids in Kawasaki disease.

Authors: 
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-03-15

4.  The Significance of Symptoms in Predicting Coronary Artery Aneurysms of Kawasaki Disease, Especially in Female Patients.

Authors:  Huan Yu; Weiyue Sun; Haoran Wu; Shuchi Zhang; Zhipeng Xu; Rongzhou Wu; Xing Rong; Huixian Qiu; Jinshun Zhu; Chunxiang Zhang; Maoping Chu
Journal:  Front Cardiovasc Med       Date:  2022-04-28

5.  Establishment and Validation of a Multivariate Predictive Scoring Model for Intravenous Immunoglobulin-Resistant Kawasaki Disease: A Study of Children From Two Centers in China.

Authors:  Changjian Li; Shu Wu; Yuanyuan Shi; Ying Liao; Yan Sun; Hui Yan; Qingyou Zhang; Jia Fu; Dan Zhou; Yong Zhang; Hongfang Jin; Junbao Du
Journal:  Front Cardiovasc Med       Date:  2022-04-27

6.  Risk Factors for Coronary Artery Lesionsin Kawasaki Disease Independent of Antibiotic Use in Chinese Children.

Authors:  Sixian Lao; Tao Zhou; Ho-Chang Kuo; Guoping Zhong; Weiwei Zeng
Journal:  Front Public Health       Date:  2022-05-05

7.  Efficacy evaluation and mechanical study of short- and long-term antithrombotic therapy for Kawasaki disease.

Authors:  Jingxia Hao; Hua Wang; Jingshi Chen; Bo Li; Huimin Zhang; Yingqian Zhang
Journal:  Transl Pediatr       Date:  2021-07

Review 8.  Anti-inflammatory Treatment of Kawasaki Disease: Comparison of Current Guidelines and Perspectives.

Authors:  Piotr Buda; Joanna Friedman-Gruszczyńska; Janusz Książyk
Journal:  Front Med (Lausanne)       Date:  2021-11-30

Review 9.  The Clinical Chameleon of Autoinflammatory Diseases in Children.

Authors:  Eugenio Sangiorgi; Donato Rigante
Journal:  Cells       Date:  2022-07-18       Impact factor: 7.666

Review 10.  The everchanging framework of autoinflammation.

Authors:  Raffaele Manna; Donato Rigante
Journal:  Intern Emerg Med       Date:  2021-05-17       Impact factor: 3.397

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.